Aurora Investment Managers’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,082
| Closed | -$206 | – | 47 |
|
|
2024
Q3 | $206 | Buy |
+2,082
| New | +$206 | 0.13% | 45 |
|
|
2024
Q2 | – | Sell |
-2,332
| Closed | -$221K | – | 53 |
|
|
2024
Q1 | $221K | Sell |
2,332
-612
| -21% | -$58K | 0.16% | 52 |
|
|
2023
Q4 | $263K | Sell |
2,944
-256
| -8% | -$22.9K | 0.2% | 44 |
|
|
2023
Q3 | $234K | Sell |
3,200
-71,543
| -96% | -$5.23M | 0.2% | 42 |
|
|
2023
Q2 | $6.22M | Sell |
74,743
-1,905
| -2% | -$159K | 4.74% | 5 |
|
|
2023
Q1 | $5.84M | Sell |
76,648
-639
| -0.8% | -$48.7K | 5.07% | 6 |
|
|
2022
Q4 | $6.42M | Buy |
77,287
+4,687
| +6% | +$389K | 6.42% | 2 |
|
|
2022
Q3 | $5.76M | Buy |
72,600
+809
| +1% | +$64.2K | 5.72% | 5 |
|
|
2022
Q2 | $5.33M | Buy |
71,791
+4,054
| +6% | +$301K | 5.15% | 5 |
|
|
2022
Q1 | $6.09M | Buy |
67,737
+346
| +0.5% | +$31.1K | 4.53% | 5 |
|
|
2021
Q4 | $7.55M | Sell |
67,391
-1,967
| -3% | -$220K | 7.22% | 5 |
|
|
2021
Q3 | $8.72M | Sell |
69,358
-2,909
| -4% | -$366K | 8.86% | 3 |
|
|
2021
Q2 | $9.79M | Buy |
72,267
+33,466
| +86% | +$4.53M | 9.77% | 2 |
|
|
2021
Q1 | $5.26M | Buy |
38,801
+4,244
| +12% | +$576K | 5.77% | 9 |
|
|
2020
Q4 | $4.87M | Buy |
34,557
+6,114
| +21% | +$861K | 4.55% | 8 |
|
|
2020
Q3 | $3.17M | Buy |
28,443
+4,287
| +18% | +$478K | 2.87% | 12 |
|
|
2020
Q2 | $2.7M | Buy |
+24,156
| New | +$2.7M | 2.19% | 14 |
|